Oligosaccharides containing three monosaccharide units linked by glycosidic bonds.
Networked: 24 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results


1. Meikle, Peter J: 2 articles (01/2005 - 05/2004)
2. Hopwood, John J: 2 articles (01/2005 - 05/2004)
3. Fuller, Maria: 2 articles (01/2005 - 05/2004)
4. Ahmad, Altaf: 1 article (01/2015)
5. Yousuf, Peerzada Yasir: 1 article (01/2015)
6. Iqbal, Muhammad: 1 article (01/2015)
7. Aref, Ibrahim M: 1 article (01/2015)
8. Ahmad, Sayeed: 1 article (01/2015)
9. Ganie, Arshid Hussain: 1 article (01/2015)
10. Pandey, Renu: 1 article (01/2015)

Related Diseases

1. Lepromatous Leprosy
2. Schistosomiasis (Bilharziasis)
3. Neoplasms (Cancer)
08/01/1998 - "Additionally, glycohistochemical features, including binding capacities for histo-blood group trisaccharides, have the potential to aid in establishment of a biologic marker set for tumor staging."
10/01/2012 - "They have been successfully used as building blocks to synthesize tailor-made di- and trisaccharides involved in the structure of lacto-N-neo-tetraose and precursors of the tumor-associated carbohydrate antigen T and the antitumoral drug peracetylated β-naphtyl-lactosamine. "
10/01/1996 - "Histochemical detection of expression of binding sites for labelled hyaluronic acid and carrier-immobilized synthetic (histo-blood group trisaccharides) or biochemically purified (ganglioside GM1) glycoligands in nasal polyps and other human lesions including neoplasms."
10/01/2002 - "Metastatic cells with low tumorogenic activity weakly expressed lectins to disaccharide ligands 6-SiaLac [Neu5Aca2-6Galb1-4Glc], 6-HSO3LacNAc, and A-di [GalNAca 1-3Galb] and trisaccharides H-type 1 [Fuca1-2Galb1-3GlcNAc and Lex [Fuca1-3(Galb 1-4)GlcNAc] compared to cells that initiated tumor formation in the syngeneic system (similarly to transplanted tumors). "
02/15/1996 - "Structural chemistry of MUC1 oligosaccharides demonstrated that the cancer-associated glycoforms carry mainly sialylated trisaccharides NeuAc alpha 2-3Gal Beta 1-3GalNAc or NeuAc alpha 2-6(Gal beta l-3)GalNAc, exhibit a concomitant decrease in the ratio of GlcNAc/GalNAc, a reduction or disappearance of L-fucose, and a partial substitution of N-acetylneuraminic acid by the N-glycolylated variant. "
4. Mucopolysaccharidosis I (Hurler Syndrome)
5. Carcinoma (Carcinomatosis)

Related Drugs and Biologics

1. Antibodies
2. Immunoglobulin M (IgM)
3. N-Acetylneuraminic Acid (Sialic Acid)
4. Lectins
5. Lactose
6. Iduronidase (alpha-L-Iduronidase)
7. Disaccharides
8. Chondroitin
9. Aggrecans (Aggrecan)
10. Mannose-Binding Lectin (Mannan-Binding Lectin)